Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VA106483 dose response in elderly males with nocturia
NCT00879138Phase 2Completed
- Sponsor
- Vantia Therapeutics
- Start
- Aug 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fedovapagon in nocturia, sponsored by Vantia Therapeutics. Started Aug 2008; status: completed.
02
Drugs
fedovapagon
03
Conditions
nocturia
Beyond the preview
Go deeper on NCT00879138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00879138.